Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 9192771)

Published in Blood on June 15, 1997

Authors

C A Hsu1, A K Rishi, X Su-Li, T M Gerald, M I Dawson, C Schiffer, U Reichert, B Shroot, G C Poirer, J A Fontana

Author Affiliations

1: Department of Medicine and Cancer Center, University of Maryland at Baltimore and the Baltimore VA Medical Center, USA.

Articles citing this

Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol (1998) 1.30

GADD45 proteins: central players in tumorigenesis. Curr Mol Med (2012) 1.26

Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. Cancer Res (2007) 1.25

Minireview: role of orphan nuclear receptors in cancer and potential as drug targets. Mol Endocrinol (2013) 1.04

The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives. Chem Rev (2013) 0.98

Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis. Proc Natl Acad Sci U S A (1998) 0.98

Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol (2003) 0.95

Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. Biochem J (1999) 0.88

Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437. Nucleic Acids Res (1999) 0.86

Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles. Eur J Med Chem (2009) 0.81

Molecular recognition and enhancement of aqueous solubility and bioactivity of CD437 by β-cyclodextrin. Bioorg Med Chem Lett (2010) 0.80

Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells. Biochem J (2000) 0.79

Adamantyl-substituted retinoid-related molecules induce apoptosis in human acute myelogenous leukemia cells. Mol Cancer Ther (2010) 0.79

The antitumor toxin CD437 is a direct inhibitor of DNA polymerase α. Nat Chem Biol (2016) 0.77

Novel cis-trans interactions are involved in post-transcriptional regulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mRNA. J Mol Signal (2010) 0.75

Articles by these authors

A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47

Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57

Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature (1992) 3.39

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29

Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol (1993) 2.07

Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res (1997) 1.96

Retinoids selective for retinoid X receptor response pathways. Science (1992) 1.91

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer (2000) 1.66

Chemotherapy for breast cancer decreases plasma protein C and protein S. J Clin Oncol (1988) 1.66

T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats. Am J Respir Cell Mol Biol (1996) 1.64

Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci U S A (1997) 1.47

The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res (1993) 1.45

Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene (1999) 1.41

Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res (1996) 1.41

Interaction of GRASP, a protein encoded by a novel retinoic acid-induced gene, with members of the cytohesin family of guanine nucleotide exchange factors. J Biol Chem (2000) 1.40

Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene (1994) 1.36

A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (1994) 1.31

Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol (1998) 1.30

The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol (2001) 1.29

Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ (1998) 1.23

13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood (1992) 1.21

Selective high affinity retinoic acid receptor alpha or beta-gamma ligands. Mol Pharmacol (1991) 1.19

Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol (1987) 1.18

Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci U S A (1980) 1.17

p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene (1995) 1.16

Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt. Oncogene (2006) 1.15

Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. Biochem Biophys Res Commun (1992) 1.13

Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12

Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol (1985) 1.11

Quantification of retinoic acid by gas-liquid chromatography-mass spectrometry: total versus all-trans-retinoic acid in human plasma. J Lipid Res (1985) 1.11

Suramin, an active nonhormonal cytotoxic drug for treatment of prostate cancer: compelling reasons for testing in patients with hormone-refractory breast cancer. J Natl Cancer Inst (1992) 1.10

Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol (1994) 1.10

Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol (1997) 1.09

Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. J Med Chem (1995) 1.09

Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst (1999) 1.08

The role of retinoic acid receptors in neurite outgrowth from different populations of embryonic mouse dorsal root ganglia. J Cell Sci (2000) 1.08

Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis (1995) 1.08

Uptake and accumulation of purine bases by stationary yeast cells pretreated with glucose. Biochim Biophys Acta (1974) 1.05

Identification and subcellular distribution of cornified envelope precursor proteins in the transformed human keratinocyte line SV-K14. J Invest Dermatol (1987) 1.05

Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia (1993) 1.05

Genomic cloning of human Echinococcus granulosus DNA: isolation of recombinant plasmids and their use as genetic markers in strain characterization. Parasitology (1987) 1.04

Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol (1998) 1.04

Synthesis and release of amphipathic gamma-glutamyl transferase by the pulmonary alveolar type 2 cell. Its redistribution throughout the gas exchange portion of the lung indicates a new role for surfactant. J Biol Chem (1994) 1.04

Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res (2000) 1.04

p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer (1997) 1.02

A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. Blood (1991) 1.02

TGT3, thyroid transcription factor I, and Sp1 elements regulate transcriptional activity of the 1.3-kilobase pair promoter of T1alpha, a lung alveolar type I cell gene. J Biol Chem (1997) 1.02

Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem (1998) 1.01

The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood (1999) 1.01

Cellular senescence mechanisms in chronic wound healing. Cell Death Differ (2005) 1.00

Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem (1994) 0.99

Classical and novel retinoids: their targets in cancer therapy. Leukemia (2002) 0.99

Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res (1995) 0.98

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis (1995) 0.97

Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res (1993) 0.97

Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity. Cancer Res (2001) 0.97

Selective synthetic ligands for human nuclear retinoic acid receptors. Skin Pharmacol (1992) 0.96

Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem (1995) 0.95

Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7. Cancer Res (1992) 0.95

Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res (1995) 0.95

Secretion and binding of transforming growth factor beta by scleroderma and normal dermal fibroblasts. Arthritis Rheum (1990) 0.95

Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog. Endocrinology (1998) 0.94

9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood (1993) 0.94

Outer root sheath cells of human hair follicle are able to regenerate a fully differentiated epidermis in vitro. Dev Biol (1988) 0.93

Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line. Proc Natl Acad Sci U S A (1981) 0.93

Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Prostate (1999) 0.93

S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid. Cancer Res (2000) 0.93

Conformationally restricted retinoids. J Med Chem (1984) 0.93

Morphological and biochemical characterization of the cornified envelopes from human epidermal keratinocytes of different origin. J Invest Dermatol (1988) 0.92

Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ (2000) 0.92

Retinoic acid induces changes in the pattern of airway branching and alters epithelial cell differentiation in the developing lung in vitro. Am J Respir Cell Mol Biol (1995) 0.92

Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437. J Cell Physiol (1997) 0.92

Retinoic acid analogues with ring modifications. Synthesis and pharmacological activity. J Med Chem (1981) 0.92

Survey of city/county public health agencies to determine the development, use, and effect of program performance standards. Am J Public Health (1986) 0.91

Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacol (1992) 0.91

A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter. Proc Natl Acad Sci U S A (1994) 0.91

Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood (1986) 0.91

Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res (1996) 0.90